October 29, 2026

FDA monthly preview: Key November decisions to watch

Upcoming FDA decisions span cancer, cardiovascular disease, rare genetic disorders, and more.

MDSpire News

October 28, 2026

PET/MRI may reveal MRI-occult inflammation

In a rare anti-vimentin encephalitis case, molecular imaging detected abnormalities that declined alongside neurologic improvement following immunotherapy.

MDSpire News

October 28, 2026

Miliary tuberculosis may masquerade as toxoplasmosis

Chest imaging and sputum testing uncovered tuberculosis in a patient whose incidental brain lesions initially suggested a parasitic infection.

MDSpire News

October 28, 2026

Anti-CGRP antibodies may raise miscarriage risk

Findings from 7,579 pregnancies suggest a potential safety concern with migraine prevention during early pregnancy.

MDSpire News

October 23, 2026

Fulminant GBS may mimic brain death

Investigators describe preserved cerebral activity, prolonged mechanical ventilation, and partial neurological recovery in patients with profound paralysis.

MDSpire News

October 22, 2026

Medical Oddities: When puberty arrives at 4 months old

A genetic mystery, hearts in space, midnight munchies, and tea with muscle power are in the lineup this week.

MDSpire News

October 21, 2026

PMOS-dementia link may reflect metabolic risks

Investigators identify insulin resistance and obesity as possible contributors to neurologic changes.

MDSpire News

October 20, 2026

Annual dementia cases may double by 2050

A global analysis reveals differences in dementia incidence by sex and country income, with implications for future prevention and care.

MDSpire News

October 16, 2026

Peanuts may improve regional brain insulin response

A randomized crossover trial found changes in insulin-induced cerebral blood flow following 16 weeks of daily peanut consumption, although the connection to improved memory remains unclear.

MDSpire News

October 15, 2026

AI may predict focal GBM recurrence

Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.

MDSpire News